These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

660 related items for PubMed ID: 18671303

  • 1. Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management.
    Ginès P, Guevara M.
    Hepatology; 2008 Sep; 48(3):1002-10. PubMed ID: 18671303
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of ascites, hyponatremia and hepatorenal syndrome in liver cirrhosis].
    Ackermann D.
    Ther Umsch; 2009 Nov; 66(11):747-51. PubMed ID: 19885792
    [Abstract] [Full Text] [Related]

  • 3. Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial.
    Ginès P, Wong F, Watson H, Milutinovic S, del Arbol LR, Olteanu D, HypoCAT Study Investigators.
    Hepatology; 2008 Jul; 48(1):204-13. PubMed ID: 18508290
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.
    Decaux G.
    J Lab Clin Med; 2001 Jul; 138(1):18-21. PubMed ID: 11433224
    [Abstract] [Full Text] [Related]

  • 6. The management of ascites and hyponatremia in cirrhosis.
    Ginès P, Cárdenas A.
    Semin Liver Dis; 2008 Feb; 28(1):43-58. PubMed ID: 18293276
    [Abstract] [Full Text] [Related]

  • 7. Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonism.
    Rai A, Whaley-Connell A, McFarlane S, Sowers JR.
    Am J Nephrol; 2006 Feb; 26(6):579-89. PubMed ID: 17170524
    [Abstract] [Full Text] [Related]

  • 8. Hyponatremia in Cirrhosis--Pathogenesis, Treatment, and Prognostic Significance.
    Sinha VK, Ko B.
    Adv Chronic Kidney Dis; 2015 Sep; 22(5):361-7. PubMed ID: 26311597
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.
    Wong F, Blei AT, Blendis LM, Thuluvath PJ.
    Hepatology; 2003 Jan; 37(1):182-91. PubMed ID: 12500203
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
    Palm C, Pistrosch F, Herbrig K, Gross P.
    Am J Med; 2006 Jul; 119(7 Suppl 1):S87-92. PubMed ID: 16843091
    [Abstract] [Full Text] [Related]

  • 13. Hyponatremia in heart failure: the role of arginine vasopressin and its antagonism.
    Rosner MH, Ronco C.
    Congest Heart Fail; 2010 Jul; 16 Suppl 1():S7-14. PubMed ID: 20653716
    [Abstract] [Full Text] [Related]

  • 14. [Vasopressin receptor antagonists: the vaptans].
    Villabona C.
    Endocrinol Nutr; 2010 May; 57 Suppl 2():41-52. PubMed ID: 21130961
    [Abstract] [Full Text] [Related]

  • 15. Vasopressin dysregulation and hyponatremia in hospitalized patients.
    Multz AS.
    J Intensive Care Med; 2007 May; 22(4):216-23. PubMed ID: 17712057
    [Abstract] [Full Text] [Related]

  • 16. Vasopressin dysregulation: hyponatremia, fluid retention and congestive heart failure.
    LeJemtel TH, Serrano C.
    Int J Cardiol; 2007 Aug 09; 120(1):1-9. PubMed ID: 17346825
    [Abstract] [Full Text] [Related]

  • 17. Vasopressin-receptor antagonists.
    Hoorn EJ, Zietse R.
    Future Cardiol; 2010 Jul 09; 6(4):523-34. PubMed ID: 20608824
    [Abstract] [Full Text] [Related]

  • 18. Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist.
    Soupart A, Gross P, Legros JJ, Alföldi S, Annane D, Heshmati HM, Decaux G.
    Clin J Am Soc Nephrol; 2006 Nov 09; 1(6):1154-60. PubMed ID: 17699341
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.